• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELWEAVE VALSALVA ANTE-FLO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELWEAVE VALSALVA ANTE-FLO Back to Search Results
Model Number 734028/10ADP
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Fever (1858); Seroma (2069)
Event Type  Injury  
Manufacturer Narrative
(b)(4).A review of manufacturing and qc records confirmed that device has been manufactured to specification.Vascutek did not receive complaints for any other units from the complaint batches or any other units that were impregnated and sterilised at the same time as the complaint device.Endotoxin results for the complaint device were reviewed and they were within the limit.As the event was reported as fever and seroma 5-year similar events review covered all infection, seroma and fever complaints for all gelweave family product types which gave a low occurrence rate of 0.002% (complaints v sales).During review of vascutek's clinical evaluation report and relevant clinical papers for polyester vascular grafts, it was noted that seroma formation is a known and expected complication of this type of procedure.As a complaint device was not available no further investigation can be carried out.Vascutek now consider this event closed; however, the event type will continue to be tracked and trended through the complaint's monitoring system.If negative trend arises corrective actions may be considered at the time.
 
Event Description
Vascutek have received notification of the event that was described as 39-degree fever after several days from the implant day.A seroma around the implanted graft was observed as well.Initially procedure was complete as usual.Patient was given antipyretic to reduce the fever and is in the recovery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE VALSALVA ANTE-FLO
Type of Device
GELWEAVE VALSALVA ANTE-FLO
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, scotland PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan business park
PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
carolyn forrest
newmains avenue
inchinnan business park
UK   PA4 9RR
MDR Report Key6710366
MDR Text Key79926036
Report Number9612515-2017-00010
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881121031
UDI-Public05037881121031
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K013022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/18/2017,07/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date08/31/2021
Device Model Number734028/10ADP
Device Catalogue Number734028/10ADP
Device Lot Number15839245-9247
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Device Age11 MO
Event Location Hospital
Date Report to Manufacturer04/18/2017
Initial Date Manufacturer Received 04/18/2017
Initial Date FDA Received07/13/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/25/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-